Chicken Anti-Mouse IgG H&L (HRP) (ab6814)
Key features and details
- Chicken Anti-Mouse IgG H&L (HRP)
- Conjugation: HRP
- Host species: Chicken
- Suitable for: Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, WB, ICC/IF
Related conjugates and formulations
製品の概要
-
製品名
Chicken Anti-Mouse IgG H&L (HRP)
IgG 二次抗体 製品一覧 -
由来種
Chicken -
ターゲット生物種
Mouse -
アプリケーション
適用あり: Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, WB, ICC/IFmore details -
免疫原
mouse IgG whole molecule
-
標識
HRP
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
pH: 6.5
Preservative: 0.01% Gentamicin sulphate
Constituents: 1% BSA, 0.424% Tripotassium orthophosphate, 0.88% Sodium chloride -
Concentration information loading...
-
精製度
Affinity purified -
特記事項(精製)
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Mouse IgG coupled to agarose. -
特記事項(標識)
Horseradish Peroxidase (HRP) -
ポリ/モノ
ポリクローナル -
研究分野
関連製品
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab6814の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
Dot blot |
Use at an assay dependent concentration.
|
|
ELISA |
Use at an assay dependent concentration.
|
|
IHC-P |
Use at an assay dependent concentration.
|
|
IHC-Fr |
Use at an assay dependent concentration.
|
|
Immunomicroscopy |
Use at an assay dependent concentration.
|
|
WB |
1/2000 - 1/10000.
|
|
ICC/IF |
1/500 - 1/2500.
|
特記事項 |
---|
Dot blot
Use at an assay dependent concentration. |
ELISA
Use at an assay dependent concentration. |
IHC-P
Use at an assay dependent concentration. |
IHC-Fr
Use at an assay dependent concentration. |
Immunomicroscopy
Use at an assay dependent concentration. |
WB
1/2000 - 1/10000. |
ICC/IF
1/500 - 1/2500. |
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
Datasheet download
参考文献 (8)
ab6814 は 8 報の論文で使用されています。
- Tevzadze G et al. Gut neurotoxin p-cresol induces brain-derived neurotrophic factor secretion and increases the expression of neurofilament subunits in PC-12 cells. AIMS Neurosci 9:12-23 (2022). PubMed: 35434277
- Musidlak O et al. The Activity of Chelidonium majus L. Latex and Its Components on HPV Reveal Insights into the Antiviral Molecular Mechanism. Int J Mol Sci 23:N/A (2022). PubMed: 36012505
- Lundberg AP et al. Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy. Neoplasia 23:811-822 (2021). PubMed: 34246985
- Dandekar P et al. Enhanced uptake and siRNA-mediated knockdown of a biologically relevant gene using cyclodextrin polyrotaxane. J Mater Chem B 3:2590-2598 (2015). PubMed: 32262906
- Okal A et al. Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model. Gene Ther : (2014). WB . PubMed: 25077773
- Reaz S et al. A single mutant, A276S of p53, turns the switch to apoptosis. Mol Pharm 10:1350-9 (2013). PubMed: 23402381
- Dixon AS et al. Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis. Mol Pharm 9:187-95 (2012). PubMed: 22136227
- Dixon AS et al. Disruption of bcr-abl coiled coil oligomerization by design. J Biol Chem 286:27751-60 (2011). WB . PubMed: 21659527